Clinical Trial Update: Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication [Phase 2]

View source ↗

Summary

An update on a Phase 2 clinical trial evaluating a biological medicine for Diffuse Intrinsic Pontine Glioma. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Intrinsic Pontine Glioma

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Diffuse Intrinsic Pontine Glioma | Phase 2 | Status: UNKNOWN